BGB-11417-105
Study consists of two parts, a part 1 dose escalation and a part 2 cohort expansion in combination with dexamethasone and carfilzomib intravenously across two cohorts with a monotherapy component as well.
Discover New Possibilities: Find Your Path to Healing through Valkyrie Clinical Trials